跳至主要内容
临床试验/NCT01217099
NCT01217099终止不适用

A Prospective, Open-label Trial of Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

Chongqing Medical University0 个研究点目标入组 47 人开始时间: 2007年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
47
主要终点
efficacy of methylprednisolone pulse macrolide therapy for children with refractory MPP.

研究概览

简要总结

The purpose of this study is planned to investigate whether small doses of methylprednisolone pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory mycoplasma pneumoniae pneumonia(MPP) .

详细描述

Corticosteroid has been used in adulthood refractory MPP with satisfactory efficacy. But there were few studies about the use of corticosteroid in children with refractory MPP. Lee KY et al indicated oral prednisolone of 1 mg/kg/ day for 1 week be useful for children with severe MPP. Akihiro T et al demonstrated that intravenously administered methylprednisolone at a dose of 30 mg/kg once daily for 3 consecutive days had an efficacious treatment for children with refractory MPP.But the methods of corticosteroid use, such as the dosage, administration route, duration of treatment have not been well understood. So in this study, we planned to investigate whether small doses of methylprednisolone pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory mycoplasma pneumoniae pneumonia in a prospective, open-label fashion.

PMID: 11096025 PMID: 18033831 PMID: 10434547 PMID: 16437541 PMID: 18656264

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • mycoplasma pneumoniae pneumonia
  • prolonged fever and deterioration of radiological findings despite macrolides treatment for 7 days or more.

排除标准

  • chronic cardiac and pulmonary disease
  • immunodeficiency
  • requiring mechanical ventilation
  • with other pathogens detected during pneumonia.

研究组 & 干预措施

methylprednisolone

No Intervention

methylprednisolone pulse azithromycin

干预措施: methylprednisolone (Drug)

azithromycin

No Intervention

azithromycin

干预措施: azithromycin (Drug)

结局指标

主要结局

efficacy of methylprednisolone pulse macrolide therapy for children with refractory MPP.

时间窗: 3-year

compare the temperature , infiltration absorption,atelectasis resolution, pleural effusion disappearance,serum levels of ferritin and LDH between methylprednisolone pulse macrolide therapy group and macrolide therapy group .

次要结局

  • safety of methylprednisolone pulse macrolide therapy for children with refractory MPP.(3-year)

研究者

发起方
Chongqing Medical University
申办方类型
Other

相似试验